This spring's Chronic Care Roundtable will explore how coordinated, team-based care must evolve amid rapid disruption in the cardiometabolic landscape. With the rise of GLP-1 therapies, expanding oral agents, growing attention to obesity, and increased patient demand for consumer health technologies, medical groups face new clinical and operational challenges. This forward-looking discussion will focus on aligning innovation with evidence-based, equitable, and outcomes-driven care across diabetes and cardiovascular disease.